David E Gerber

David E Gerber

UNVERIFIED PROFILE

Are you David E Gerber?   Register this Author

Register author
David E Gerber

David E Gerber

Publications by authors named "David E Gerber"

Are you David E Gerber?   Register this Author

100Publications

2421Reads

33Profile Views

Patient and provider perspectives on delivery of oral cancer therapies.

Patient Educ Couns 2019 Nov 20;102(11):2102-2109. Epub 2019 Jun 20.

Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2019.06.019DOI Listing
November 2019

Definition and Coordination of Roles and Responsibilities Among Cancer Center Clinic and Research Personnel.

J Oncol Pract 2019 Oct 7:JOP1900315. Epub 2019 Oct 7.

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00315DOI Listing
October 2019

Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.

Cancer 2019 Sep 10. Epub 2019 Sep 10.

Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32377
Publisher Site
http://dx.doi.org/10.1002/cncr.32377DOI Listing
September 2019

Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors.

JAMA Netw Open 2019 Sep 4;2(9):e1911519. Epub 2019 Sep 4.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2019.11519DOI Listing
September 2019

Conceptual Model for Accrual to Cancer Clinical Trials.

J Clin Oncol 2019 Aug 5;37(23):1993-1996. Epub 2019 Jun 5.

1The University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00101DOI Listing
August 2019

Stakeholder engagement to initiate lung cancer screening in an urban safety-net health system.

Healthc (Amst) 2019 Aug 31:100370. Epub 2019 Aug 31.

Division of Hematology-Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA; Medical Oncology Clinic, Parkland Health & Hospital System, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hjdsi.2019.100370DOI Listing
August 2019

Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.

Semin Cancer Biol 2019 Jul 19. Epub 2019 Jul 19.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9093, United States; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9093, United States; Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9093, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2019.06.012DOI Listing
July 2019

Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice.

Transl Lung Cancer Res 2019 Jun;8(3):202-207

Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.09.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626864PMC
June 2019

NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers.

Clin Cancer Res 2019 Apr 7;25(8):2601-2609. Epub 2019 Jan 7.

Department of Biochemistry and Molecular Biology, Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-2560DOI Listing
April 2019

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.

Cancer Inform 2019 5;18:1176935119837547. Epub 2019 Apr 5.

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1176935119837547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452590PMC
April 2019

Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases.

Clin Lung Cancer 2019 03 29;20(2):e152-e157. Epub 2018 Nov 29.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX; Harold C. Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX; Veterans Affairs, North Texas Health Care System, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.11.008DOI Listing
March 2019

Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?

J Thorac Oncol 2019 Mar;14(3):332-335

Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.017DOI Listing
March 2019

Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?

Cancers (Basel) 2019 Mar 15;11(3). Epub 2019 Mar 15.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11030366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468595PMC
March 2019

Hyperprogressive disease: a distinct effect of immunotherapy?

J Thorac Dis 2019 Mar;11(Suppl 3):S262-S265

Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2019.01.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424758PMC
March 2019

Mobile Device Applications for Electronic Patient Portals in Oncology.

JCO Clin Cancer Inform 2019 02;3:1-8

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.18.00094DOI Listing
February 2019

Immune dysregulation in cancer patients developing immune-related adverse events.

Br J Cancer 2019 01 31;120(1):63-68. Epub 2018 Oct 31.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0155-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325132PMC
January 2019

Development and Validation of a Nomogram Prognostic Model for SCLC Patients.

J Thorac Oncol 2018 09 11;13(9):1338-1348. Epub 2018 Jun 11.

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.037DOI Listing
September 2018

Statistical justification of expansion cohorts in phase 1 cancer trials.

Cancer 2018 08 5;124(16):3339-3345. Epub 2018 Jul 5.

Department of Statistical Science, Southern Methodist University, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108930PMC
August 2018

Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers.

Stat Med 2018 07 23;37(16):2516-2529. Epub 2018 Apr 23.

Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.7691DOI Listing
July 2018

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis.

Lung Cancer 2018 06 19;120:22-26. Epub 2018 Mar 19.

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, 75390, USA; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, 75390, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.03.011DOI Listing
June 2018

Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.

Lancet Respir Med 2018 06;6(6):472-478

Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30172-3DOI Listing
June 2018

Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database.

Oncotarget 2018 May 11;9(36):24470-24479. Epub 2018 May 11.

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966260PMC
May 2018

Characteristics of Patients Using Patient Portals in Oncology.

JAMA Oncol 2018 Mar;4(3):416-418

Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2017.5257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885824PMC
March 2018

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

JAMA Oncol 2018 Jan 11;4(1):e173501. Epub 2018 Jan 11.

Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833648PMC
January 2018

How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis.

Lung Cancer 2018 01 24;115:97-102. Epub 2017 Nov 24.

Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, United States; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, United States; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.11.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751945PMC
January 2018

Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?

Authors:
David E Gerber

J Oncol Pract 2018 01;14(1):32-34

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2017.028290
Publisher Site
http://dx.doi.org/10.1200/JOP.2017.028290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765903PMC
January 2018

Cancer Center Clinic and Research Team Perceptions of Identity and Interactions.

J Oncol Pract 2017 12 13;13(12):e1021-e1029. Epub 2017 Oct 13.

Purdue University, West Lafayette, IN; and University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.024349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728363PMC
December 2017

Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials.

Clin Lung Cancer 2017 11 8;18(6):626-630. Epub 2017 May 8.

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.04.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673582PMC
November 2017

Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

J Thorac Oncol 2017 10 9;12(10):1489-1495. Epub 2017 Aug 9.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610621PMC
October 2017

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.

Lung Cancer 2017 10 23;112:195-199. Epub 2017 Aug 23.

Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road Washington DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.017DOI Listing
October 2017

Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer.

J Thorac Oncol 2017 09 21;12(9):1446-1450. Epub 2017 Jun 21.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572747PMC
September 2017

Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial.

Contemp Clin Trials 2017 09 5;60:78-85. Epub 2017 Jul 5.

Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2017.07.003DOI Listing
September 2017

Chemotherapy for Advanced Non-small Cell Lung Cancer.

Cancer Treat Res 2016;170:119-49

Harold C. Simmons Cancer Center, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 8852, Dallas, TX, 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40389-2_6DOI Listing
June 2017

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.

Br J Cancer 2017 Mar 14;116(6):717-725. Epub 2017 Feb 14.

Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355931PMC
March 2017

Oncology Nursing Perceptions of Patient Electronic Portal Use: A Qualitative Analysis.

Oncol Nurs Forum 2017 03;44(2):165-170

University of Texas Southwestern Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1188/17.ONF.165-170DOI Listing
March 2017

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition.

Lung Cancer 2017 03 11;105:14-16. Epub 2017 Jan 11.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States; The Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.01.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330183PMC
March 2017

ALK alterations and inhibition in lung cancer.

Semin Cancer Biol 2017 02 13;42:81-88. Epub 2016 Sep 13.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2016.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316306PMC
February 2017

Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple Myeloma.

J Clin Oncol 2017 02 17;35(6):580-582. Epub 2017 Jan 17.

Ethan A. Halm, Larry D. Anderson Jr, and David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.4726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771641PMC
February 2017

A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.

Transl Cancer Res 2017 Feb;6(Suppl 1):S78-S82

Department of Internal Medicine (Division of Hematology-Oncology), Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center. Dallas, Texas. USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tcr.2017.02.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495191PMC
February 2017

Upper lip metastasis of sarcomatoid carcinoma of the lung - an unusual site of disease: a case report.

J Med Case Rep 2017 Jan 19;11(1):18. Epub 2017 Jan 19.

Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, 2201 Inwood Road, 3rd Floor, Suite 500, Dallas, TX, 75390-9125, USA.

View Article

Download full-text PDF

Source
http://jmedicalcasereports.biomedcentral.com/articles/10.118
Publisher Site
http://dx.doi.org/10.1186/s13256-016-1178-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244539PMC
January 2017

Increase in Cancer Center Staff Effort Related to Electronic Patient Portal Use.

J Oncol Pract 2016 12 31;12(12):e981-e990. Epub 2016 Oct 31.

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.011817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455586PMC
December 2016

Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.

Ann Transl Med 2016 Dec;4(24):529

Division of Hematology-Oncology, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.12.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233507PMC
December 2016

Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options.

JAMA Oncol 2016 Nov;2(11):1507-1508

Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656433PMC
November 2016

Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems.

J Oncol Pract 2016 11 30;12(11):1020-1028. Epub 2016 Sep 30.

University of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455413PMC
November 2016

Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 09 27;34(25):2969-79. Epub 2016 Jun 27.

Naiyer A. Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; Julie R. Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Rosalyn A. Juergens, Juravinski Cancer Centre at McMaster University, Hamilton; Scott A. Laurie, Ottawa Hospital Cancer Centre, Ottawa; Frances A. Shepherd, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Scott Gettinger, Yale Cancer Center, New Haven, CT; Laura Q. Chow, University of Washington, Seattle, WA; David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX; Jonathan W. Goldman, University of California, Los Angeles, Los Angeles, CA; Allen C. Chen, Yun Shen, Faith E. Nathan, and Christopher T. Harbison, Bristol-Myers Squibb, Princeton, NJ; and Scott Antonia, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.66.9861
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.66.9861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569693PMC
September 2016

Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 09 27;34(25):2980-7. Epub 2016 Jun 27.

Scott Gettinger, Yale Cancer Center, New Haven, CT; Naiyer A. Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; Laura Q. Chow, University of Washington, Seattle, WA; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Neal Ready, Duke University Medical Center, Durham, NC; David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX; Frances A. Shepherd, Princess Margaret Cancer Centre, Toronto; Rosalyn A. Juergens, Juravinski Cancer Centre at McMaster University, Hamilton; Scott A. Laurie, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; Scott Antonia, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Jonathan W. Goldman, University of California, Los Angeles, Los Angeles, CA; and Faith E. Nathan, Yun Shen, and Christopher T. Harbison, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569692PMC
September 2016

Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.

J Thorac Oncol 2016 08 26;11(8):1357-1362. Epub 2016 Apr 26.

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961571PMC
August 2016

Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.

Lung Cancer 2016 08 31;98:106-113. Epub 2016 May 31.

Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, United States; Harold C. Simmons Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.05.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939247PMC
August 2016

Performance Status-Based Oncology Practice Guidelines: Easier Said Than Done.

Authors:
David E Gerber

J Oncol Pract 2016 07 21;12(7):597-9. Epub 2016 Jun 21.

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013128DOI Listing
July 2016

Choroid plexus papilloma-A case highlighting the challenges of extrapolating pediatric chemotherapy regimens to adult populations.

J Oncol Pharm Pract 2016 Feb 25;22(1):170-4. Epub 2014 Jul 25.

Department of Internal Medicine, University of Texas Southwestern Medical Center, USA Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1078155214544075
Publisher Site
http://dx.doi.org/10.1177/1078155214544075DOI Listing
February 2016

Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies.

Am Soc Clin Oncol Educ Book 2015 :147-62

From The University of Texas Southwestern Medical Center, Dallas, TX; Memorial Sloan Kettering Cancer Center, New York, NY; Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.147DOI Listing
February 2016

Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in Cancer.

JAMA Oncol 2016 Jan;2(1):132-3

Harold C. Simmons Cancer Center, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3788DOI Listing
January 2016

Management and future directions in non-small cell lung cancer with known activating mutations.

Am Soc Clin Oncol Educ Book 2014 :e353-65

From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e353DOI Listing
December 2015

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.

Lung Cancer 2015 Dec 9;90(3):534-41. Epub 2015 Oct 9.

Department of Internal Medicine (Division of Hematology-Oncology), USA; Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125089PMC
December 2015

Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.

Am J Nucl Med Mol Imaging 2015 12;5(5):493-503. Epub 2015 Oct 12.

Department of Radiology, University of Texas Southwestern Medical Center Dallas, Texas 75390-8852, USA ; Department of Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center Dallas, Texas 75390-8852, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620176PMC
November 2015

Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?

Clin Transl Sci 2015 Oct 15;8(5):526-32. Epub 2015 Jan 15.

Clinical & Translational Science Institute, University of Rochester Medical Center, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cts.12255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503515PMC
October 2015

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Oct 27;373(17):1627-39. Epub 2015 Sep 27.

From the Fox Chase Cancer Center, Philadelphia (H.B.); Hospital Universitario Virgen del Rocio, Seville (L.P.-A.), Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Hospital de Madrid, Norte Sanchinarro, Madrid (E.H.) - all in Spain; Vanderbilt-Ingram Cancer Center (L.H.), and Sarah Cannon Research Institute and Tennessee Oncology (D.R.S.) - both in Nashville; Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) and Robert-Bosch-Krankenhaus Stuttgart, Gerlingen (M.K.) - both in Germany; Duke University Medical Center, Durham, NC (N.E.R.); University of Washington, Seattle (L.Q.C.); University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.), Centre Léon Bérard, Lyon (J.F.), and Centre Hospitalier Universitaire de Rennes, Rennes (H.L.) - all in France; Instituto Nacional de Cancerologia, Mexico City (O.A.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Forlì-Cesena (M.A.B.), and Ospedale di Perugia, Perugia (L.C.) - both in Italy; N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); University of Texas Southwestern Medical Center, Dallas (D.E.G.); Yale Comprehensive Cancer Center, New Haven, CT (S.N.G.); Memorial Sloan Kettering Cancer Center, New York (C.M.R., N.R.); University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.J.A.); Bristol-Myers Squibb, Princeton, NJ (C.D., C.T.H., F.G.F.); and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.R.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936PMC
October 2015

Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.

J Thorac Oncol 2015 Sep;10(9):e86-e88

Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158309PMC
September 2015

Should criteria for inclusion in cancer clinical trials be expanded?

J Comp Eff Res 2015 Aug;4(4):289-91

Harold C Simmons Cancer Center, 5323 Harry Hines Blvd, 8590, Dallas, TX 75390-8590, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer.15.27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838010PMC
August 2015

Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.

Oncologist 2015 Jun 27;20(6):674-82. Epub 2015 May 27.

Division of Hematology-Oncology, Department of Internal Medicine, Department of Cell Biology, Division of Biostatistics, Department of Clinical Sciences, and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Oncology Clinic, Parkland Health and Hospital System, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2015-0083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571795PMC
June 2015

Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

J Natl Cancer Inst 2015 Apr 9;107(4). Epub 2015 Feb 9.

Department of Internal Medicine (ALL, EAH, DEG), Department of Clinical Sciences (SLP, LX, EAH), Harold C. Simmons Cancer Center (SLP, EAH, DEG), University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djv002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402360PMC
April 2015

Impact of NCI-mandated scientific review on protocol development and content.

J Natl Compr Canc Netw 2015 Apr;13(4):409-16

From School of Medicine, Harold C. Simmons Cancer Center, Department of Clinical Sciences, and Department of Internal Medicine, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. From School of Medicine, Harold C. Simmons Cancer Center, Department of Clinical Sciences, and Department of Internal Medicine, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119526PMC
http://dx.doi.org/10.6004/jnccn.2015.0056DOI Listing
April 2015

Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways.

Clin Pharmacol 2015 27;7:57-68. Epub 2015 Mar 27.

Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA ; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA ; Harold C Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CPAA.S79760DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381889PMC
April 2015

Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation.

J Clin Oncol 2015 Feb 10;33(5):e25-6. Epub 2014 Mar 10.

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.1985DOI Listing
February 2015

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

J Thorac Oncol 2015 Jan;10(1 Suppl 1):S1-63

*Department of Medical Oncology, Washington University School of Medicine, Saint Louis, Missouri; Departments of †Medical Oncology and ‡Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; §Department of Medical Oncology, University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado; ‖UCLA Santa Monica Hematology Oncology, Santa Monica, California; ¶Division of Hematology-Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; #Department of Medical Oncology, Yale School of Medicine and Cancer Center, New Haven, Connecticut; **Massachusetts General Hospital Cancer Center, Boston, Massachusetts; ††Department of Oncology, The University of Chicago Medicine, Chicago, Illinois; ‡‡Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; §§Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia; ‖‖Memorial Sloan-Kettering Cancer Center, New York, New York; ¶¶Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina; ##Sarah Cannon Research Institute, Nashville, Tennessee; ***The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; †††Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; and ‡‡‡Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346098PMC
January 2015

Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

J Clin Oncol 2014 Dec 27;32(34):3824-30. Epub 2014 Oct 27.

Puneeth Iyengar, Zabi Wardak, Irma Smith, Chul Ahn, David E. Gerber, Jonathan Dowell, Randall Hughes, Ramzi Abdulrahman, Hak Choy, Robert Timmerman, University of Texas Southwestern Medical Center, Dallas, TX; Brian D. Kavanagh, D. Ross Camidge, Laurie E. Gaspar, Robert C. Doebele, and Paul A. Bunn, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.7412
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.7412DOI Listing
December 2014

Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer.

Lung Cancer 2014 Nov 24;86(2):231-6. Epub 2014 Aug 24.

UT Southwestern Medical Center, Dallas, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.08.010DOI Listing
November 2014

Impact of prior cancer on eligibility for lung cancer clinical trials.

J Natl Cancer Inst 2014 Nov 24;106(11). Epub 2014 Sep 24.

Harold C. Simmons Cancer Center (DEG, EAH, SLP), Department of Internal Medicine (DEG, ALL, EAH), and Department of Clinical Sciences (LX, EAH, SLP), University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271029PMC
November 2014

Intramedullary spinal cord hemorrhage after treatment with bevacizumab in a long-term survivor with metastatic non-small-cell lung cancer.

J Thorac Oncol 2014 Aug;9(8):e60-1

*Division of Hematology/Oncology; and †Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153065
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000172DOI Listing
August 2014

Simultaneous acute myeloid leukemia and mesothelioma diagnoses in a long-term survivor of the 1984 Bhopal gas leak.

Acta Oncol 2014 Jul 23;53(7):984-8. Epub 2014 Jan 23.

Division of Hematology-Oncology, University of Texas Southwestern Medical Center , Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.879609DOI Listing
July 2014

Should family physicians routinely screen for lung cancer in high-risk populations? Yes: CT-based screening is complex but worthwhile.

Authors:
David E Gerber

Am Fam Physician 2014 Jul;90(2):73B-4B

Harold C. Simmons Cancer Center at the University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
July 2014

Stigma among patients with lung cancer: a patient-reported measurement model.

Psychooncology 2014 Jan 3;23(1):81-92. Epub 2013 Oct 3.

Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936675PMC
January 2014

A reevaluation of CD22 expression in human lung cancer.

Cancer Res 2014 Jan;74(1):263-71

Authors' Affiliations: Cancer Immunobiology Center and Hamon Center for Therapeutic Oncology Research; Departments of Immunology, Internal Medicine, Microbiology, Pathology, and Pharmacology, University of Texas Southwestern Medical Center, Dallas; Departments of Thoracic/Head and Neck Medical Oncology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston; Bio-Synthesis Inc., Lewisville, Texas; and Department of Immunology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903042PMC
January 2014

Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.

Clin Lung Cancer 2013 Nov 22;14(6):644-50. Epub 2013 Jul 22.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628749PMC
November 2013

Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer.

J Thorac Oncol 2013 Oct;8(10):1308-16

*University of Texas Southwestern, Dallas, Texas; †ACORN and West Clinic, Memphis, Tennessee; ‡Cancer Center of Kansas, Wichita, Kansas; §UCLA/Translational Oncology Research International Network, Los Angeles, Los Angeles; ‖Alamance Regional Medical Center, Burlington, North Carolina; ¶Washington University, St. Louis, Missouri; and #Lilly USA, LLC, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182a02546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715866PMC
October 2013